Course Listing
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Browse All MDS Courses
New courses are added regularly. If there are not courses listed in the category you are searching, more will be scheduled at a later date. Check back soon or sign up for email notifications.
Please wait while we gather your results.
Diagnosis and Treatment of Cerebellar Ataxias
Live OnlineEurope
Jul 13, 2026 - Jul 14, 2026
Foundational / Beginner
1093 The <em>MDS-ES Diagnosis and Treatment of </em><em>Cerebellar </em><em>Ataxias</em> online course will firstly cover the basics such as the cerebellar functional anatomy and the clinical examination of an ataxia patient, after which the comprehensive diagnostic approach and therapeutic management strategies will be presented and discussed.<br /><br /><strong>Registration Deadline:</strong> July 10, 2026 Ataxias, Biomarkers & Diagnostic Tools, Clinical Trials, Complementary and Alternative Medicine, Etiology & Pathophysiology, Exercise, Genetics, Neuroimaging, Non-invasive stimulation, Nutritional Therapy, Occupational Therapy, Other Movement Disorders, Physical Therapy/Physiotherapy, Psychiatry, Psychology/Psychotherapy, Sexual Health, Social Work, Speech Therapy, Therapies-Other, Therapies-Pharmacological 480 0.00 https://education.movementdisorders.org/Detail/1093/MDS-ES-Diagnosis-and-Treatment-of-Cerebellar-Ataxias https://education.movementdisorders.org/Upload/ActivityImages/26ESMD_202x108282855.png https://education.movementdisorders.org/Upload/BannerImages/26ESMD_734x404693440.jpg 2026-07-13T00:00:00 2026-07-14T00:00:00 MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ESMD Online Course Schedule_no faculty_07042026112836.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1733945513728_11122024013152.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ESMD Online Course Schedule_no faculty_07042026112836.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong></a><strong> </strong><strong> </strong> <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS_07042026112812.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1733945513883_11122024013153.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS_07042026112812.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a><strong> </strong></p><p><span style="color: rgb(184, 49, 47);"><br></span></p><p><strong>REGISTRATION FEES</strong><br><strong>MDS Members: </strong>$0 USD<br><strong>Non-Members: </strong>$50 USD<br><em>*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><br></p><p><strong>COURSE SCHEDULE</strong><strong><em> </em></strong></p><p>Monday, July 13, 2026 | 14:00 - 17:30 CET<br>Tuesday, July 14, 2026 | 14:00 - 17:30 CET</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Describe the key cerebellar structures, their role and appearance on MRI brain scans</p><p>2. List the most common causes of acquired, genetic and degenerative ataxias</p><p>3. Identify the best diagnostic strategy in case of cerebellar ataxia</p><p>4. Summarize current treatment options in cerebellar ataxias</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>The target audience is movement disorder specialists, general neurologists, clinical fellow, movement disorders fellows, neurology residents, physio / physical therapists, speech therapists, genetic counselors, and psychologists.</p> 0 /Courses/Diagnosis-and-Treatment-of-Cerebellar-Ataxias.htm Diagnosis and Treatment of Cerebellar Ataxias 2026-04-07T15:01:09.690 0 0 Foundational / Beginner Clinician Clinician-General Neurologist Clinician-Movement Disorder Specialist Fellow Fellow-Clinical Fellow-Movement Disorders Health Professional Health Professional-Genetic Counseling Health Professional-Physio / Physical Health Professional-Psychologists Health Professional-Speech Resident Resident-Neurology English Europe Live Online
Botulinum Toxin Guided Injection Workshop for Cervical and other Focal Dystonias
In-PersonEurope
Dublin, Ireland
Jun 12, 2026 - Jun 13, 2026
Experienced / Intermediate
1091 <p style="line-height:107%;">In this course, experts in botulinum toxin treatment and EMG/ultrasound, will provide practical lectures and hands-on teaching for optimizing patient assessment, selecting a treatment plan, and optimizing toxin injection technique. Teaching modalities include lectures, videos, case-based examples and small group hands on sessions.<br /></p> Botulinum toxin, Clinical Trials, Deep brain stimulation, Focused Ultrasound, Gene Therapies, Infusion therapy, Therapies-Pharmacological, Therapies-Surgical 570 0.00 https://education.movementdisorders.org/Detail/1091/MDS-ES-Botulinum-Toxin-Guided-Injection-Workshop-for-Cervical-and-other-Focal-Dystonias https://education.movementdisorders.org/Upload/ActivityImages/26ESBotox_202x108316145.jpg https://education.movementdisorders.org/Upload/BannerImages/esskill721553.jpg 2026-06-12T00:00:00 2026-06-13T00:00:00 Dublin MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ES%20BoTN%20Program_No%20Faculty_24032026041739.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ES%20BoTN%20Program_No%20Faculty_24032026041739.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong></a><strong> </strong><strong> <strong><a href="https://form.jotform.com/260355109437153" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Travel assistance_23012024043912.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong></strong><a href="https://form.jotform.com/260814798453165" rel="noopener noreferrer" target="_blank"><strong><strong><strong>Travel Bursary</strong></strong></strong></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ES%20BoTN%20Faculty%20Listing_24032026041826.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ES%20BoTN%20Faculty%20Listing_24032026041826.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of March 24, 2026</em><br><strong><em><span style="color: rgb(175, 38, 38);">Course Application</span><span style="color: rgb(184, 49, 47);"> Deadline: </span></em></strong><em><span style="color: rgb(184, 49, 47);">April </span></em><em><span style="color: rgb(184, 49, 47);">10, 2026</span></em><br><em><span style="color: rgb(184, 49, 47);"><strong>Travel Bursary Application Deadline: </strong>April 10, 2026</span></em><em><span style="color: rgb(184, 49, 47);"><br></span></em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $275 USD</p><p><strong>Junior / No Fee Members:</strong> $250 USD<br><strong>Non-Members*:</strong> $350 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><br></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Friday, June 12, 2026 from 13:00 - 19:15</p><p>Day 2: Saturday, June 13, 2026 from 9:00 - 17:10<br><br><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p><span style="background-color: null;">Pillar Center</span></p><p><span style="background-color: null;">Mater Misericordiae University Hospital</span></p><p><span style="background-color: null;">Eccles St, Phibsborough, Dublin, Ireland </span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><ol><li><span style="color: rgb(0, 0, 0);">Describe the different phenomologies of cervical dystonia, limb dystonia, and cranial dystonia</span></li><li><span style="color: rgb(0, 0, 0);">Identify muscles to target for injections, and design treatment plans</span></li><li><span style="color: rgb(0, 0, 0);">Recognize EMG and ultrasound guidance techniques to enhance toxin delivery</span></li><li><span style="color: rgb(0, 0, 0);">List strategies to troubleshoot suboptimal outcomes</span></li></ol><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is designed for movement disorder specialist physicians and fellows</p> Dublin 0 /Courses/Botulinum-Toxin-Guided-Injection-Workshop-for-Cervical-and-other-Focal-Dystonias.htm Botulinum Toxin Guided Injection Workshop for Cervical and other Focal Dystonias 2026-03-24T18:01:10.210 0 0 Experienced / Intermediate Clinician Clinician-Movement Disorder Specialist Fellow-Movement Disorders Researcher-Clinical Resident-Neurology English Europe In-Person Ireland
Journal CME 41.03: Parkinson’s-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001088 <p>The Journal CME 41.03 article aims to test the hypothesis that LRRK2 and GBA modify the human peripheral immune response to bacteria, specifically P. aeruginosa, based on prior animal studies involving Lrrk2 mutations and microbial pathogens.</p> Autoimmune, Basic/Translational Neuroscience, Environmental Risk factors, Etiology & Pathophysiology, Genetics, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD) Julian R. Mark 60 1.00 https://education.movementdisorders.org/Detail/1088/Journal-CME-41-03:-Parkinson’s-Linked-LRRK2-and-GBA1-Mutations-Modulate-the-Peripheral-Immune-Response-to-Pseudomonas-aeruginosa https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-03-18T00:00:00 2027-03-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.03%20-%20Disclosures_17032026110315.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Evaluate the impact of LRRK2 and GBA1 mutations on peripheral immune responses in Parkinson’s disease</p><p>2. Assess the effects of LRRK2 inhibition and glucocerebrosidase activation on cytokine signaling and immune cell function</p><p>3. Understand mechanisms linking peripheral immune dysregulation to Parkinson’s disease pathogenesis</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.03-Parkinsons-Linked-LRRK2-and-GBA1-Mutations-Modulate-the-Peripheral-Immune-Response-to-Pseudomonas-aeruginosa.htm Journal CME 41.03: Parkinson’s-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa Journal CME 41.03 2026-03-18T12:01:06.157 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA
MDS Case Presentation: A 4-Year-Old With Spells of Inbalance
On Demand
Case Presentation Series
15 Minutes
Foundational / Beginner
943 This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case of a 4 year-old patient with spells of inbalance. Biomarkers, Biomarkers & Diagnostic Tools, Care Models, Dystonia, Gait & Balance Disorders, Genetic & Hereditary Disorders, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Nutritional Therapy, Other Movement Disorders, Pediatrics, Rating Scales, Therapies-Other Claudio M. De Gusmao, MD, PhD 15 0.00 https://education.movementdisorders.org/Detail/943/MDS-Case-Presentation:-A-4-Year-Old-With-Spells-of-Inbalance https://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg https://education.movementdisorders.org/Upload/BannerImages/caseimg746707.jpg 2026-03-17T00:00:00 2029-03-17T00:00:00 MDS Education <p><strong>FACULTY</strong></p><p>Claudio M. De Gusmao, MD, PhD - Mass General Brigham/Harvard Medical School, Boston, MA, United States</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/MDS-Case-Presentation-A-4-Year-Old-With-Spells-of-Inbalance.htm MDS Case Presentation: A 4-Year-Old With Spells of Inbalance 2026-03-17T03:00:51.610 0 0 Foundational / Beginner Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student Case Presentation Series English On-Demand USA
Train the Trainer Program for Speech and Language Therapists - Trainer Application
In-PersonEurope
Salerno, Italy
Sep 17, 2026 - Sep 18, 2026
Foundational / Beginner
1087 <p>The MDS-ES Train the Trainer Program for Speech and Language Therapists seeks to support the training of speech and language therapists to identify common movement disorders and advise on appropriate next steps in the diagnosis, management, and care of patients with movement disorders. The MDS Train the Trainer Program (TTP) will take place June - October 2026 using the Train the Trainer education model, wherein MDS provides centralized curriculum, resources, training and support to regionally identified trainers, who in turn utilize these materials to prepare and implement training programs for allied health professionals in their local languages and organizations.<br /></p> Ataxias, Chorea/Huntingtons Disease (HD), Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Freezing of Gait (FOG), Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Hyperkinetic Movement Disorders, Lewy-body dementia (LBD), Movement Disorders Emergencies, Multiple Systems Atrophy (MSA), Myoclonus, Non-motor Symptoms/Disorders, Other Movement Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rare/Uncommon Movement Disorders, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Speech Disorders, Speech Therapy, Stiff Person syndrome (SPS), Therapies-Other, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) 870 0.00 https://education.movementdisorders.org/Detail/1087/MDS-ES-Train-the-Trainer-Program-for-Speech-and-Language-Therapists---Trainer-Application https://education.movementdisorders.org/Upload/ActivityImages/26ESTTP_202x10892189.png https://education.movementdisorders.org/Upload/BannerImages/26ESTTP_734x404318891.jpg 2026-09-17T00:00:00 2026-09-18T00:00:00 Salerno <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ESTTP In-Person Training Schedule_no faculty_16032026115934.pdf" rel="noopener noreferrer" target="_blank"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747846457039_21052025115416.png" class="fr-fic fr-dii"></a><!--[endif]--><strong>Course Schedule</strong><strong> </strong><!--[if !vml]--><!--[endif]--><strong> </strong><!--[if !vml]--><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747846457070_21052025115417.png" class="fr-fic fr-dii"><!--[endif]--><strong>Course Faculty</strong></p><p><br></p><p><strong><em><span style="color: rgb(184, 49, 47);">Application</span></em></strong><span style="color: rgb(184, 49, 47);"> <em><strong>Deadline:</strong></em></span><em><span style="color: rgb(184, 49, 47);"><strong> </strong>April 30, 2026</span></em></p><p><br></p><p><strong>TRAIN THE TRAINER FOR SPEECH AND LANGUAGE THERAPISTS: BACKGROUND</strong></p><p>The MDS Train the Trainer Program (TTP) will occur beginning in mid-2026 and ending in mid-2027 using the Train the Trainer education model, wherein MDS provides centralized curriculum, resources, training and support to regionally identified trainers, who in turn utilize these materials to prepare and implement training programs for allied health professionals in their local languages and organizations.<br><br><strong>PROGRAM OVERVIEW</strong><br>The MDS-ES Train the Trainer Pilot Program occurs from June 2026 – July 2027.<br><br><strong><span style="color: rgb(184, 49, 47);">Accepted Trainers must complete all components of the MDS-ES Train the Trainer Program outlined below.</span></strong><br><br></p><ul><li><strong>Online Education: June – September 2026</strong><br>Participate in online lectures and discussion. Additional information on dates and format will be shared during the orientation call.<br><em>Supplemental online modules will be provided to attendees. It is expected that all attendees planning to apply for the in-person Train the Trainer Program</em><span style="box-sizing: border-box; margin: 0px; padding: 0px;"><em><strong><span style="color:rgb(184, 49, 47);"> </span></strong></em></span><span style="color: rgb(0, 0, 0);"><em>for Speech and Language Therapists complete these online modules.</em></span><br><br></li><li><strong>In-Person Workshop: September 17-18, 2025 – Salerno, Italy</strong><br>Required in-person workshop scheduled for September 17-18, 2026 in Salerno, Italy. MDS will provide travel support for Trainers to participate in person.<br><em>IMPORTANT: In-person participation at the Workshop is <strong><u>mandatory</u></strong> for acceptance in the program. If you cannot attend the Workshop, please do not apply for the program.</em><br><br></li><li><strong>Discussion of Local Training Plans: September – October 2026</strong><br>Trainers will present and discuss their Local Training Implementation Plans with a faculty mentor prior to implementation.<br><br></li><li><strong>Implementation of Local Training Program: November 2026 – July 2027</strong><br>Trainers prepare and implement the local training programs in their home institutions or other appropriate setting. Trainers must complete the training and required event reporting before the end of July 2027.</li></ul><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>1. Describe the specific communication and swallowing needs of patients with Movement Disorders</p><p>2. Indicate and discuss the most appropriate assessment tools -clinical and instrumental- to use for communication and swallowing problems of patients with Movement Disorders</p><p>3. Integrate information and propose a treatment plan based on evidence and Movement Disorders-specific clinical needs</p><p>4. Evaluate and revise the management of communication and swallowing </p><p>5. Plan and present a local training program to transfer learning to colleagues</p><p><br><strong>INTENDED AUDIENCE</strong></p><p>The MDS-ES Train the Trainer Program is intended for speech and language therapists residing within the MDS-European Section.<br><br><em>Eligible applicants must:</em></p><ul><li>Be a credentialed allied health professional with a current affiliation at a hospital, clinic, or medical school</li><li>Be a current MDS Member residing and practicing within the MDS-European Section</li><li>Have the ability to host training for allied health professionals in local institution. (Local training can be presented in English or local language.)</li><li>Provide verification of permission from Institution/Department Director to participate in MDS-ES Train the Trainer Program (June 2026 – October 2026), including in person attendance at the Training Workshop (September 17-18, 2026, Salerno, Italy)</li><li>Provide verification of ability and permission to coordinate and implement a local training session at home institution or appropriate national society event (November 2026 – July 2027)</li></ul> Salerno 0 /Courses/Train-the-Trainer-Program-for-Speech-and-Language-Therapists---Trainer-Application.htm Train the Trainer Program for Speech and Language Therapists - Trainer Application 2026-03-16T15:01:21.190 0 0 Foundational / Beginner Health Professional-Speech English Europe In-Person Italy
School for Young Neurologists
In-PersonEurope
London, United Kingdom, UK
Jul 16, 2026 - Jul 18, 2026
Foundational / Beginner
1086 <p>The MDS-ES School for Young Neurologist is designed for young neurologists and early-career movement disorder specialists who wish to deepen their expertise in the field of movement disorders, with particular focus on clinical examination, diagnosis and treatment. The program offers a comprehensive overview of main movement disorders and of recent developments on genetics, digital health and treatment with device aided therapies. Teaching will be delivered by internationally known experts from specialized movement disorder centre.</p><p><strong>Applications Closed</strong><strong></strong></p> Biomarkers, Biomarkers & Diagnostic Tools, Botulinum toxin, Clinical Trials, Deep brain stimulation, Dopaminergic medications, Focused Ultrasound, Gene Therapies, Genetics, Infusion therapy, Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Rating Scales, Therapies-Pharmacological, Therapies-Surgical 1260 0.00 https://education.movementdisorders.org/Detail/1086/MDS-ES-School-for-Young-Neurologists https://education.movementdisorders.org/Upload/ActivityImages/26ESSYN_202x108554660.png https://education.movementdisorders.org/Upload/BannerImages/26ESSYN_734x404520523.jpg 2026-07-16T00:00:00 2026-07-18T00:00:00 London, United Kingdom <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course%20Agenda%20MDS%20ES%20SYN%20London%20NO%20Faculty_11032026080456.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course%20Agenda%20MDS%20ES%20SYN%20London%20NO%20Faculty_11032026080456.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong><strong> </strong></a><strong> <strong><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Travel assistance_23012024043912.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></strong></strong><a href="https://form.jotform.com/260635929151157" rel="noopener noreferrer" target="_blank"><strong><strong><strong>Travel Bursary</strong></strong></strong></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_11032026085243.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_11032026085243.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of March 11, 2026 </em><br><strong><em><span style="color: rgb(175, 38, 38);">Course Application</span><span style="color: rgb(184, 49, 47);"> Deadline: </span></em></strong><em><span style="color: rgb(184, 49, 47);">April </span></em><em><span style="color: rgb(184, 49, 47);">1, 2026</span></em><br><em><span style="color: rgb(184, 49, 47);"><strong><em><span style="color: rgb(175, 38, 38);">Travel Bursary Application</span><span style="color: rgb(184, 49, 47);"> Deadline: </span></em></strong><em><span style="color: rgb(184, 49, 47);">April </span></em><em><span style="color: rgb(184, 49, 47);">1, 2026</span></em></span></em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $250 USD<br><strong>Non-Members*:</strong> $325 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Thursday, July 16, 2026 from 8:00 - 19:00<br>Day 2: Friday, July 17, 2026 from 8:30 - 21:30</p><p>Day 3: Saturday, July 18, 2026 from 8:00 - 13:00<br><br><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p>St George’s University Hospital, </p><p>Blackshaw Road, SW17 0QT</p><p>London, United Kingdom</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. To perform a structured and comprehensive clinical evaluation of patients presenting with movement disorders.<br>2. To present and analyze movement disorder case histories using a structured and evidence-based approach.<br>3. To deliver accurate diagnoses in patients with common and straightforward movement disorder presentations.<br>4. To formulate and critically appraise differential diagnoses in patients with complex or atypical movement disorder presentations.<br>5. To develop, evaluate, and appropriately modify individualized management plans in accordance with current evidence and best clinical practice.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is designed for young neurologists and early-career movement disorder specialists who wish to deepen their expertise in the field of movement disorders</p> London, United Kingdom 0 /Courses/School-for-Young-Neurologists3.htm School for Young Neurologists 2026-03-11T12:01:06.837 0 0 Foundational / Beginner Clinician Fellow-Clinical Fellow-Movement Disorders Resident-Neurology Europe In-Person UK
MDS Parkinson's Disease Educational Course for Industry Professionals
In-Person
Phoenix, USA
May 23, 2026
Foundational / Beginner, Experienced / Intermediate
1082 <p>As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner. The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.</p><p> </p><p style="text-align:center;"><strong>This program will take place on May 23, 2026 in Phoenix, AZ, USA ahead of the World Parkinson’s Congress</strong><strong></strong><em></em></p><p style="text-align:center;"><em> </em></p><p><em>*<strong>15% discount</strong> for companies who send 3+ participants and either supported the 2025 MDS International Congress or have committed support for the 2026 International Congress in Seoul, Korea </em></p> 480 0.00 https://education.movementdisorders.org/Detail/1082/MDS-Parkinson's-Disease-Educational-Course-for-Industry-Professionals https://education.movementdisorders.org/Upload/ActivityImages/Copenhagen-course-LMS-image360304.png 2026-05-23T00:00:00 2026-05-23T00:00:00 Sheraton Phoenix Downtown, Phoenix, Arizona <p>This activity is intended for industry professionals who work for pharmaceutical and medical device companies.</p> <p>As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner. </p><p><br></p><p>There will be a patient/caregiver roundtable session in the program to enrich the participant’s knowledge on how PD impacts patients and their caregivers. </p><p><br></p><p>The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.</p><p><br></p><p><em><strong>Registration Fees</strong></em></p><p><strong>Members: </strong>$800 USD</p><p><strong>Non-Members:</strong> $800 USD</p><p><em><br></em></p><p><em><span data-teams="true">*<strong>15% discount</strong> for companies who send 3+ participants and either supported the 2025 MDS International Congress or have committed support for the 2026 International Congress in Seoul, Korea</span> </em></p> <p>Upon completion of this activity, learners will be able to:</p><p>1. Recognize the differential diagnosis of Parkinson’s disease</p><p>2. Discuss the clinical features of Parkinson’s disease from early to advanced stages</p><p>3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery</p><p>4. Discuss non-motor features of Parkinson’s disease</p><p>5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s d</p> <p><strong>Course Director</strong></p><p>Connie Marras, MD, PhD; University of Toronto; Toronto, Canada</p><p><br></p><p><strong>Faculty</strong></p><p>To be announced soon</p> MDS Development Phoenix 0 /Courses/MDS-Parkinsons-Disease-Educational-Course-for-Industry-Professionals1.htm MDS Parkinson's Disease Educational Course for Industry Professionals 2026-02-27T15:01:10.407 0 0 Foundational / Beginner Experienced / Intermediate Industry In-Person USA
Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001076 <p>The Journal CME 41.02 article aims to investigate potential differences in muscle activity between ID and FD patients using polyelectromyography (PEMG) under anesthesia.</p> Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Functional Movement Disorders, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Other Movement Disorders, Rating Scales Roberto Eleopra, MD 60 1.00 https://education.movementdisorders.org/Detail/1076/Journal-CME-41-02:-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia:-A-Pilot-Study https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-02-19T00:00:00 2027-02-19T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.02%20-%20Disclosures_16022026081618.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the diagnostic overlap between functional and idiopathic dystonia and the need for objective biomarkers</p><p>2. Evaluate the role of sedation-based PEMG findings in differentiating FD from ID</p><p>3. Assess the clinical utility and limitations of EMG patterns under anesthesia in the diagnostic workup of dystonia</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.02-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia-A-Pilot-Study.htm Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study Journal CME 41.02 2026-02-19T09:01:11.360 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA
Genetic Counseling in Parkinson's Disease
On Demand
60 Minutes
Foundational / Beginner
CME Credits:1.001050 Genetics has become an important clinical tool and can also identify people at risk for disease. This is an introductory module on genetic counseling and testing for Parkinson’s disease and includes some of the most important aspects to consider. Biomarkers & Diagnostic Tools, Genetics, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD) Deborah Raymond, MS, CGC, Maya Rawal, MS, CGC, Rachel Saunders Pullman, MD, MPH , MS 60 1.00 https://education.movementdisorders.org/Detail/1050/Genetic-Counseling-in-Parkinson's-Disease https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-45-001-Genetic-Counseling-202x108969975.jpg 2026-02-16T00:00:00 2029-02-16T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Genetic Counseling in Parkinson's Disease _17122025113848.pdf" rel="noopener noreferrer" target="_blank">HERE.</a> All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Deborah Raymond, MS, CGC - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p>Maya Rawal, MS, CGC - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p>Rachel Saunders-Pullman, MD, MPH, MS - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand the principal components of genetic counseling for Parkinson’s disease</p><p>2. Understand the most common genetic contributors to Parkinson’s disease </p><p>3. Understand genetic testing types</p><p>4. Understand the meaning of test results and how genetic variants are interpreted</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Genetic-Counseling-in-Parkinsons-Disease.htm Genetic Counseling in Parkinson's Disease 2026-02-16T15:01:04.617 0 0 Foundational / Beginner Clinician Health Professional Resident Student CME On-Demand USA
Journal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001074 <p>The Journal CME 41.01 article aims to investigate cross-sectional and longitudinal associations between baseline cerebrospinal fluid (CSF) PENK concentration and regional brain atrophy, compared identified patterns with CSF neurofilament light (NfL), and evaluated PENK and NfL for discriminating between HD Integrated Staging System (HD-ISS) stage 0 versus 1 in a far-from-onset HD gene-expanded (HDGE) cohort.</p> Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Hyperkinetic Movement Disorders Mena Farag, MBBS, MRCP 60 1.00 https://education.movementdisorders.org/Detail/1074/Journal-CME-41-01:-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntington's-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-02-11T00:00:00 2027-02-11T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.01%20-%20Disclosures_06022026033938.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the biological rationale for CSF proenkephalin as a striatum-specific biomarker in Huntington’s disease<br>2. Assess associations between baseline CSF PENK and longitudinal regional brain atrophy compared with neurofilament light<br>3. Evaluate the role of CSF PENK in distinguishing early HD-ISS stages and its potential value for clinical trial enrichment<br><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.01-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntingtons-Disease.htm Journal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease Journal CME 41.01 2026-02-11T12:01:11.930 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA